Lakes and ponds are a long way from the rats, termites and washroom hygiene most people associate with Rentokil Initial (LSE:RTO). That gap explains the latest deal from the FTSE 100 pest control group. On 22 September 2026 it agreed to sell SOLitude Lake Management, a US Business that looks after lakes, ponds and shorelines, to Investment firm Bain Capital for $230m.

The sale has been agreed but not yet completed, and it still needs US competition clearance. Management presents it as part of a wider effort to simplify the group, cut Debt and focus on the markets where it sees the best growth. It comes at a time when shareholders are already asking questions about the pace of growth in North America.

A tidy-up in the US portfolio

SOLitude describes itself as the leading lake and pond management company in the US. Its services include water quality control, lake and pond management, and shoreline restoration. It sits some distance from Rentokil's core pest control business, although it shares the same model of recurring, route-based field services.

Bain Capital is paying $230m on a cash-free, debt-free basis. Rentokil expects net cash proceeds, after tax, of about $180m. Completion is expected early in the fourth quarter of 2026, subject to clearance under the Hart-Scott-Rodino Act, the standard US antitrust review for deals of this kind.

Chief executive Mike Duffy said the sale reflects the "simplification of the organisation" and a focus on the group's highest-opportunity markets and categories.

What the price says about the deal

In 2025, SOLitude generated Revenue of $112m and adjusted operating profit of $16m. The headline price therefore values the business at a little over twice its annual sales and about 14 times its operating profit. That is a respectable exit multiple for a business Rentokil no longer sees as central.

The deal is small against the group as a whole. Rentokil reported revenue of $3,589m for the first half of 2026 alone, so SOLitude's annual sales are only a small fraction of group turnover. The strategic signal matters more than the size.

Rentokil says it will use the proceeds to reduce Leverage and to support its capital allocation priorities. These are investment in organic growth, bolt-on acquisitions, a progressive dividend, and returns of capital to shareholders. Net debt was $3,575m at the half-year stage, and leverage had already fallen to 2.4 times EBITDA from 2.8 times, inside the group's target range of 2.0 to 2.5 times. The sale should give that measure a little more room.

Why simplification matters now

The deal needs to be read alongside Rentokil's half-year results, published on 30 July. Revenue rose 4.5% at constant currency to $3,589m, and operating profit rose 6.6% to $556m, with the Margin up 30 basis points to 15.5%. The interim Dividend was increased by 8%, and full-year profit guidance was kept in line with expectations.

The market reaction focused on growth, and the shares slipped on growth worries. North America, the group's largest region since the 2022 purchase of Terminix, grew organic revenue by 3.7%, but pest control services there managed only 2.6%. Management flagged weaker residential lead flow, particularly in termite work in north-eastern housing markets. Chief financial officer Paul Lister also said the company was retiring its 2027 target of a 20% margin in North America, because it "no longer aligns with our strategy".

The picture was not all weak. North American business services grew organic revenue by 10.6%, and the North American pest control margin rose 140 basis points to 19.7%. The International region grew organically by 3.5%, with pest control up 4.1% and Hygiene & Wellbeing up 2.6%. Management also targeted cash conversion above 80%.

Against that backdrop, selling a non-core US operation makes sense as a way to focus management time and capital on residential and commercial pest control. Duffy has set out customer focus, sales and operational excellence, and business simplification as his main priorities. Disposals such as SOLitude are the most visible part of the last of these.

Pest control remains an attractive industry, with needs-based demand, high levels of recurring contract revenue and a fragmented market that suits bolt-on acquisitions. Those are the qualities Rentokil wants investors to focus on.

The risks behind a sensible deal

A simpler group is not the same as a faster-growing one. The central issue for Rentokil is whether it can revive organic growth in North American pest control, where competition is strong and the housing market affects Demand for termite and residential services. The SOLitude sale does not fix that.

There is also a small Earnings cost. Removing $16m of annual operating profit will dilute group profit slightly until the proceeds are reinvested or used to cut interest costs. Whether the deal adds value over time depends on how well the $180m is redeployed.

Execution risk remains in the wider plan. The Terminix integration has been a long and complex process, and dropping the North America margin target leaves investors with less clarity about medium-term profitability. Completion of the sale also depends on regulatory clearance, although a deal of this size is not usually seen as contentious.

Checkpoints for the months ahead

The first milestone is completion of the SOLitude sale, which Rentokil expects early in the fourth quarter. Investors will then look for confirmation of how the proceeds are used, and whether further disposals follow as part of the simplification drive.

Rentokil normally publishes a third-quarter trading update in October. It will be the next chance to see whether North American pest control growth has improved and whether residential demand has stabilised. Full-year results early next year should give a clearer picture of margins, leverage and any new medium-term targets to replace the retired 2027 ambition.

Conclusion

The SOLitude sale is a modest but tidy move. Rentokil (LSE:RTO) gets a reasonable price for a business outside its core, a little more Balance Sheet headroom and a clearer focus on pest control. It does not answer the bigger question about growth in North America, and that is likely to drive how the shares perform from here.